Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
457.36
-5.77 (-1.25%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
68
69
Next >
2 Nasdaq 100 Stocks with Competitive Advantages and 1 Facing Challenges
November 05, 2025
While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that...
Via
StockStory
Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday?
↗
November 04, 2025
Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date...
Via
Benzinga
Earnings Scheduled For November 3, 2025
↗
November 03, 2025
Via
Benzinga
VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook
November 04, 2025
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) met Wall Streets revenue expectations in Q3 CY2025, with sales up 11% year on year to $3.08 billion. The company’s outlook for the full year was...
Via
StockStory
Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Q3 In Line With Expectations
November 03, 2025
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) met Wall Streets revenue expectations in Q3 CY2025, with sales up 11% year on year to $3.08 billion. The company’s outlook for the full year was...
Via
StockStory
Vertex Pharma Dips Despite Quarterly Beat And Slight Guidance Book
↗
November 03, 2025
Vertex stock dipped late Monday despite better-than-expected third-quarter metrics and a slight sales guidance boost.
Via
Investor's Business Daily
Vertex Reports Third Quarter 2025 Financial Results
November 03, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
↗
November 03, 2025
Via
Benzinga
Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?
↗
November 03, 2025
Wall Street opened the week on a mixed note on Monday.
Via
Benzinga
2 Healthcare Stocks for Individual Investors With a 20-Year Time Horizon
↗
November 03, 2025
These healthcare stocks are making strides in very important ways.
Via
The Motley Fool
Topics
Intellectual Property
Inflation-Proof Investing: Which Growth Stock Will Double Your Money in 6 Years?
↗
November 03, 2025
These are great picks with or without soaring inflation.
Via
The Motley Fool
Topics
Economy
Government
World Trade
My Top Growth Stock to Buy in November
↗
November 02, 2025
This stock isn't bulletproof. But it should be a big winner over the coming years.
Via
The Motley Fool
Vertex Pharmaceuticals (VRTX) Q3 Earnings: What To Expect
November 01, 2025
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results this Monday after market hours. Here’s what you need to know.
Via
StockStory
How Royalty Pharma Prints Cash Without Biotech's Biggest Risks
↗
October 31, 2025
Via
MarketBeat
Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today
↗
October 30, 2025
Via
Benzinga
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Fundamentals and Bullish Technical Setup
↗
October 29, 2025
Discover how Vertex Pharmaceuticals (VRTX) combines strong fundamentals, like high profitability and no debt, with a bullish technical breakout pattern for potential growth.
Via
Chartmill
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These
↗
October 28, 2025
These two have been neglected by Wall Street too much.
Via
The Motley Fool
Vertex to Participate in the UBS Global Healthcare Conference on November 11
October 27, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030
↗
October 27, 2025
Vertex appears to be by far the better buy right now.
Via
The Motley Fool
Topics
Intellectual Property
The Best Stocks to Invest $50,000 In Right Now
↗
October 24, 2025
There's no guarantee that any stock will deliver positive returns. But the odds look good for these three.
Via
The Motley Fool
Topics
Artificial Intelligence
Energy
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference
October 23, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Value Investment Case Study
↗
October 20, 2025
Vertex Pharmaceuticals (VRTX) presents a value investing case with strong profitability, a debt-free balance sheet, and a valuation that appears attractive relative to its industry peers.
Via
Chartmill
2 Growth Stocks to Invest $1,000 in Right Now
↗
October 19, 2025
These companies have a habit of beating the market, and they are far from having peaked.
Via
The Motley Fool
Topics
Artificial Intelligence
World Trade
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week
October 17, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
2 Soaring Cathie Wood Stocks to Buy and Hold
↗
October 17, 2025
These companies' market-beating fuel hasn't run out yet.
Via
The Motley Fool
Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market
↗
October 16, 2025
Bank of America initiates coverage on Vera Therapeutics, citing strong potential for atacicept, its kidney treatment.
Via
Benzinga
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Offers Affordable Growth in Biotech
↗
October 15, 2025
Vertex Pharmaceuticals (VRTX) offers strong growth, solid earnings, and a robust financial position, all at a reasonable price compared to biotech peers.
Via
Chartmill
2 Unstoppable Growth Stocks to Buy During a Market Crash
↗
October 15, 2025
Here are two smart ways to prepare for the next market downturn.
Via
The Motley Fool
Topics
Government
Stocks
World Trade
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
↗
October 14, 2025
Via
Benzinga
4 Healthcare Stocks to Buy Now
↗
October 12, 2025
As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.
Via
The Motley Fool
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
68
69
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.